We are live on
!
Find out more
US Bancorp Portfolio holdings
AUM
$82.4B
1-Year Est. Return
19.69%
This Fund
S&P 500
This Quarter
Est. Return
+8.01%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$39.1B
AUM Growth
+$2.42B
(+6.6%)
Cap. Flow
-$248M
Cap. Flow
% of AUM
-0.63%
Top 10 Holdings %
Top 10 Hldgs %
22.64%
Holding
3,845
New
218
Increased
1,110
Reduced
1,483
Closed
148
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell Mid-Cap ETF
IWR
|
+$45.6M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$40.7M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$38.8M |
| 4 |
iShares S&P 500 Value ETF
IVE
|
+$35.5M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$34.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$80.2M |
| 2 |
Copart
CPRT
|
+$55.9M |
| 3 |
US Bancorp
USB
|
+$47.8M |
| 4 |
IBDK
iShares iBonds Dec 2019 Term Corporate ETF
IBDK
|
+$25.8M |
| 5 |
iShares Floating Rate Bond ETF
FLOT
|
+$17.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.27% |
| 2 | Financials | 10.78% |
| 3 | Industrials | 9.91% |
| 4 | Healthcare | 9.19% |
| 5 | Consumer Staples | 6.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
The Mosaic Company
MOS
$7.09B
| $665K | ﹤0.01% |
30,721
+2,354
| +8% | +$46.7K |
|
1227
Trip.com Group
TCOM
$27.5B
| $664K | ﹤0.01% |
19,788
+652
| +3% | +$21K |
|
|
STOR
1228
DELISTED
STORE Capital Corporation
STOR
| $664K | ﹤0.01% |
17,850
-4,159
| -19% | -$161K |
|
1229
Marcus Corp
MCS
$732M
| $662K | ﹤0.01% |
20,852
-42,235
| -67% | -$1.43M |
|
|
PRAH
1230
DELISTED
PRA Health Sciences, Inc.
PRAH
| $661K | ﹤0.01% |
5,947
+2,728
| +85% | +$281K |
|
1231
Scholastic
SCHL
$796M
| $660K | ﹤0.01% |
17,163
+281
| +2% | +$10.6K |
|
1232
CVB Financial
CVBF
$3.98B
| $658K | ﹤0.01% |
30,499
+2,744
| +10% | +$58.1K |
|
|
COUP
1233
DELISTED
Coupa Software Incorporated
COUP
| $658K | ﹤0.01% |
4,505
+605
| +16% | +$86.4K |
|
1234
UBS Group
UBS
$170B
| $656K | ﹤0.01% |
52,153
+14,727
| +39% | +$175K |
|
1235
Howmet Aerospace
HWM
$116B
| $655K | ﹤0.01% |
27,752
-6,131
| -18% | -$137K |
|
1236
Flowserve
FLS
$9.25B
| $654K | ﹤0.01% |
13,137
+1,100
| +9% | +$52.7K |
|
1237
First Trust Capital Strength ETF
FTCS
$7.88B
| $654K | ﹤0.01% |
10,827
-643
| -6% | -$37.5K |
|
1238
Honda
HMC
$36.5B
| $654K | ﹤0.01% |
23,068
+2,152
| +10% | +$59.9K |
|
1239
Azenta
AZTA
$1.26B
| $649K | ﹤0.01% |
15,445
-7,571
| -33% | -$318K |
|
|
MAGN
1240
Magnera Corp
MAGN
$488M
| $648K | ﹤0.01% |
2,726
+390
| +17% | +$86.7K |
|
|
PCH
1241
DELISTED
PotlatchDeltic
PCH
| $647K | ﹤0.01% |
14,938
-1
| -0% | -$43 |
|
1242
Tradeweb Markets
TW
$21.3B
| $647K | ﹤0.01% |
13,959
+7,871
| +129% | +$339K |
|
|
CXP
1243
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $647K | ﹤0.01% |
30,978
-2,955
| -9% | -$60.6K |
|
|
FARM
1244
DELISTED
Farmer Brothers
FARM
| $646K | ﹤0.01% |
42,900
| – | – |
|
1245
Steven Madden
SHOO
$3.12B
| $641K | ﹤0.01% |
14,899
-1,327
| -8% | -$53.6K |
|
1246
Franklin Resources
BEN
$16.9B
| $640K | ﹤0.01% |
24,652
-17,255
| -41% | -$469K |
|
1247
Graham Holdings Company
GHC
$4.97B
| $640K | ﹤0.01% |
1,001
+108
| +12% | +$69.1K |
|
1248
iShares US Healthcare ETF
IYH
$3.11B
| $640K | ﹤0.01% |
14,845
| – | – |
|
1249
Royal Gold
RGLD
$17.1B
| $640K | ﹤0.01% |
5,238
+47
| +0.9% | +$5.56K |
|
1250
First Horizon
FHN
$12.1B
| $639K | ﹤0.01% |
38,647
+21,969
| +132% | +$357K |
|
Similar funds
US Bancorp's Q4 2019 Portfolio in Review
As of Q4 2019, US Bancorp held 3,845 positions worth $39.1B, up 6.6% from $36.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
US Bancorp's Q4 2019 filing shows 218 new, 1,110 increased, 1,483 reduced and 148 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M. The largest sale was Celgene Corp, an estimated $80.2M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.
- US Bancorp's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M.
- US Bancorp added most to iShares Russell Mid-Cap ETF in Q4 2019, an estimated $45.6M increase.
- US Bancorp's biggest Q4 2019 reduction was Copart, cutting an estimated $55.9M.
- US Bancorp fully exited Celgene Corp in Q4 2019, selling an estimated $80.2M.
- US Bancorp's ten largest holdings make up 23% of its $39.1B portfolio in Q4 2019.
- US Bancorp opened 218 new positions and closed 148 in Q4 2019.
- US Bancorp's portfolio value rose 6.6% quarter-over-quarter to $39.1B.
Based on US Bancorp's 13F filing for Q4 2019, filed 4 Feb 2020.